Transforms high-potential healthcare IP into acquisition-ready assets in 18–30 months via an Expedited Innovation Platform that uses AI-driven discovery, structured patenting, milestone-based financing, regulatory expertise, and early buyer alignment. Partners with research institutions, medical professionals, and investors to move innovations into patients, providers, and health systems.